A driver’s frustrating check-engine saga is making the rounds after a repair estimate swung from “brace yourself” to “that’ll ...

It is where AI faces its hardest test: layers of regulation, life-or-death stakes, complex biology, and a deeply human, ...

Upstream Bio will progress verekitug to a registrational Phase III trial in severe asthma. Image credit: Victoria Nevzorova via ShutterStock.com. Upstream Bio’s stock value took a 47% downturn ...

Upstream Bio (UPB) lost ~12% in the premarket on Wednesday even after the company said that a mid-stage trial for its experimental asthma therapy, verekitug, succeeded, paving the way for the drug's ...

Despite the selloff, Upstream Bio plans to advance verekitug into Phase 3 trials for both severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) following regulatory interactions. The ...

In a statement sent to Rigzone by the Enverus team recently, Enverus subsidiary Enverus Intelligence Research (EIR) said U.S. upstream M&A “regained momentum” in the fourth quarter of 2025. “After a ...

Global upstream oil investment is set to fall for a second straight year in 2026. Producers prioritize capital discipline amid sub-$60 oil prices, with cuts in North America and Europe offsetting ...

Shares of inflammatory disease biotech Upstream Bio, Inc. (UPB) have rallied by roughly 60% since reporting potentially best-in-class data for its asset verekitug in a Phase 2 trial in early September ...

If you build engines, tune cars, or even just like mashing your foot on the throttle with conviction, you’ve probably heard the term “wideband O2 sensor” being thrown around at the track, dyno ...

This all-purpose presence sensor is a master at monitoring indoor activity and linking it to smart home features you already use. Tyler has worked on, lived with and tested all types of smart home and ...